In the case of acute migraine treatment, the triptans and ditans are serotonin agonists with affinity to receptors 5-HT1B, D, and F that reduce symptoms of migraine including hypersensitivity, cortical spreading depression (CSD), and vasodilation during migraine attacks [38, 39, 51]. The gene discussed is HTR1B; the disease is migraine disorder.